424 research outputs found
Using Principles of International Law to Reshape American Legislation of State Official English Laws;Note
6th International Conference on Water Resources and Environment Research „Water & Environmental Dynamics” in Koblenz, Deutschland
Outcome Predictors in a Two-Phase Model and Microbiology Findings
Einleitung: Die Studienlage zur Prognose und zu Prognosefaktoren von Patienten
mit schwerer Sepsis und Neutropenie auf Intensivstationen ist begrenzt und
häufig wird diesen Patienten ein schlechter Outcome vorausgesagt. Ziel dieser
Arbeit war (I) die Bestimmung der Mortalität jener Patienten im klinischen
Alltag. Zusätzlich sollten Faktoren gefunden werden, welche Einfluss auf den
Krankheitsverlauf nehmen (II) und Hypothesen kreiert werden, um die Prognose
der Patienten zu verbessern (III). Methodik: Es wurden retrospektiv auf
Grundlage der Patientenakte alle Patienten mit einer Neutropenie untersucht,
welche sich von 2006 bis 2011 auf der Intensivstation I43 oder I47 des Virchow
Klinikums der Charité Berlin in Behandlung befanden.1 558 Patienten mit
Neutropenie konnten identifiziert werden, von denen 102 Patienten die
Einschlusskriterien erfüllten. Anhand des Krankheitsverlaufes wurde ein 2
-Phasen-Modell entwickelt. In der ersten Phase wurde unterschieden, ob
Patienten die initiale Sepsis überwunden haben oder verstorben sind. In der
zweiten Phase bzw. Genesungsphase wurden die Patienten betrachtet, welche die
Aufnahmekrise bewältigten und im Verlauf auf der Intensivstation verstorben
sind oder ihren Aufenthalt überlebten und auf eine Normalstation verlegt
worden sind. Ergebnisse: Die Gesamtmortalität der Patienten mit schwerer
Sepsis und Neutropenie auf ITS betrug 54,9%. Signifikante Parameter bezüglich
der Überwindung der primären Sepsis waren die Schwere der Sepsis bei Aufnahme
sowie die Anzahl bzw. Schwere der Organversagen. Ein anhaltendes Organversagen
sowie anhaltend erhöhte CRP-Werte waren in der Genesungsphase mit einem
negativen Outcome der Patienten assoziiert. Weitere Faktoren mit einer
Verschlechterung des Outcomes waren: Bluttransfusionen, eine nicht adäquate
antibiotische Therapie zu Beginn der Behandlung, eine CMV-Infektion oder wenn
eine Infektion mit Pilzen bzw. resistenten Erregern vorlag. Eine signifikant
erhöhte Sterblichkeitsrate und deutlich erhöhte systemische
Entzündungsparameter konnten bei Infektionen mit koagulase-negativen
Staphylokokken und bei Infektionen mit Enterokokken gefunden werden. Ob es
sich dabei um ein Epiphänomen handelt oder die Nachweise von Kokken
tatsächlich ursächlich verantwortlich sind, kann aus den vorliegenden Daten
nicht gesagt werden. Schlussfolgerung: Die Schwere der initialen Sepsis (erste
Phase) und die anhaltenden Dysfunktionen von Organen (zweite Phase) waren mit
einer schlechten Outcome-Prognose assoziiert. In Anbetracht der hohen Rate und
der schlechten Prognose von Patienten mit gram-positiven Kokken könnte eine
frühzeitige antibiotische Therapie mit Wirksamkeit gegen dieses
Erregerspektrum die Prognose von Patienten eventuell verbessern.Introduction: Presently there is only limited data on the prognosis and
prognostic factors of patients with neutropenic sepsis treated in the ICU.
Generally these patients are considered to have a very poor prognosis with
regarding survival. The aims of this work were (I) to determine the mortality
of these patients, (II) to identify prognostic factors and arguably most
importantly (III) to generate hypotheses how to improve the prognosis of these
patients. Methods: All patients with neutropenia admitted between 2006 and
2011 into the ICU I43 or I47 of the “Virchow Klinikum” - one of three clinic
locations of the “Charité Berlin” - were analyzed retrospectively. Data were
retrieved from the electronic patient records. 558 Patients with neutropenia
have been identified and 102 of them fulfilled the inclusion criteria. Based
on the course of disease a two-phase model of the ICU stay was developed. The
first phase we focused whether the patients survived the initial sepsis. In
the second or so called recovery phase we subdivided the patients into the
group which after overcoming the initial sepsis survived the stay in the ICU
or died in the subsequent course of their stay. Results: The overall ICU
mortality of patients with a neutropenic sepsis was 54,9%. Parameters
associated with overcoming the primary sepsis were the severity of the initial
sepsis and the severity of organ failures. Associated with a poor outcome in
the phase of recovery were the persistent of organ failures and persistent
higher CRP-levels. Other factors associated with poor outcome were blood
transfusions, an inappropriate initial antibiotic therapy, an infection with
CMV or a fungal infection or the detection of multiresistant bacteria. A
significantly higher mortality and a higher degree of systemic inflammation
were observed in infections with coagulase-negative Staphylococci and in
infections with Enterococci. Conclusion: Severity of the sepsis (in the first
phase) and persistent organ dysfunction (in the second phase) were associated
with unfavorably outcome. Considering the high rate and worse prognosis of
gram-positive cocci early treatment with antibiotics with respective
effectivity may improve the prognosis
Neutropenic sepsis in the ICU: Outcome predictors in a two-phase model and microbiology findings
Objective. Patients with neutropenic sepsis have a poor prognosis. We aimed to identify outcome predictors and generate hypotheses how the care for these patients may be improved. Methods. All 12.352 patients admitted between 2006 and 2011 to the medical ICUs of our tertiary university center were screened for neutropenia; out of 558 patients identified, 102 fulfilled the inclusion criteria and were analyzed. Severity markers and outcome predictors were assessed. Results. The overall ICU mortality was 54.9%. The severity of sepsis and the number of organ failures predicted survival of the primary septic episode (APACHE II 22.8 and 29.0; SOFA 7.3 and 10.1, resp.). In the recovery phase, persistent organ damage and higher persistent C-reactive protein levels were associated with a poor outcome. Blood transfusions and CMV infection correlated with an unfavorable prognosis. Ineffective initial antibiotic therapy, fungal infections, and detection of multiresistant bacteria displayed a particularly poor outcome. Infections with coagulase-negative staphylococci and enterococci were associated with a significantly higher mortality and a high degree of systemic inflammation. Conclusion. Patients with persistent organ dysfunction show an increased mortality in the further course of their ICU stay. Early antimicrobial treatment of Gram-positive cocci may improve the outcome of these patients
Upregulation of Mrps18a in breast cancer identified by selecting phage antibody libraries on breast tissue sections
Abstract
Background
One of the hallmarks of cancer is an altered energy metabolism, and here, mitochondria play a central role. Previous studies have indicated that some mitochondrial ribosomal proteins change their expression patterns upon transformation.
Method
In this study, we have used the selection of recombinant antibody libraries displayed on the surface of filamentous bacteriophage as a proteomics discovery tool for the identification of breast cancer biomarkers. A small subpopulation of breast cells expressing both cytokeratin 19 and cytokeratin 14 was targeted using a novel selection procedure.
Results
We identified the mitochondrial ribosomal protein s18a (Mrps18a) as a protein which is upregulated in breast cancer. However, Mrps18a was not homogeneously upregulated in all cancer cells, suggesting the existence of sub-populations within the tumor. The upregulation was not confined to cytokeratin 19 and cytokeratin 14 double positive cells.
Conclusion
This study illustrates how phage display can be applied towards the discovery of proteins which exhibit changes in their expression patterns. We identified the mitochondrial protein Mrps18a as being upregulated in human breast cancer cells compared to normal breast cells
Deep Infiltrating Colorectal Endometriosis Treated With Robotic-Assisted Rectosigmoidectomy
Background and Objective: Deep infiltrating pelvic endometriosis with bowel involvement is one of the most aggressive forms of endometriosis. Nowadays, robotic technology and telemanipulation systems represent the latest developments in minimally invasive surgery. the aim of this study is to present our preliminary results and evaluate the feasibility of robotic-assisted laparoscopic colorectal resection for severe endometriosis.Methods: Between September 2009 and December 2011, 10 women with colorectal endometriosis underwent surgery with the da Vinci robotic surgical system (Intuitive Surgical, Sunnyvale, CA, USA). We evaluated the following parameters: short-term complications, clinical outcomes and long-term follow-up, pain relief recurrence rate, and fertility outcomes.Results: Extensive ureterolysis was required in 8 women (80%). Ovarian cystectomy with removal of the cystic wall was performed in 7 women (70%). Torus resection was performed in all women, with unilateral and bilateral uterosacral ligament resection in 1 woman (10%) and 8 women (80%), respectively. in addition to segmental colorectal resection in all cases, partial vaginal resection was necessary in 2 women (20%). An appendectomy was performed in 2 patients (20%). the mean operative time with the robot was 157 minutes (range, 90-190 minutes). the mean hospital stay was 3 days. Six patients had infertility before surgery, with a mean infertility time of 2 years. After a 12-month follow-up period, 4 women (67%) conceived naturally and 2 (33%) underwent in vitro fertilization.Conclusion: We show that robotic-assisted laparoscopic surgery for the treatment of deep infiltrating bowel endometriosis is feasible, effective, and safe.Univ São Paulo, Hosp Clin, Fac Med, São Paulo, BrazilCtr Endometriose São Paulo, São Paulo, BrazilAlbert Einstein Hosp, São Paulo, BrazilUniversidade Federal de São Paulo, São Paulo, BrazilDigimagem Med Diagnost, Radiol Brazilian Coll, São Paulo, BrazilUniv Cent Florida, Dept Obstet & Gynecol, Orlando, FL 32816 USAFlorida Hosp Celebrat Hlth, Celebration, FL USAUniversidade Federal de São Paulo, São Paulo, BrazilWeb of Scienc
- …